Report cover image

Grindeks AS - Strategic SWOT Analysis Review

Publisher GlobalData
Published Feb 16, 2026
Length 28 Pages
SKU # GBDT20881540

Description

Grindeks AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Grindeks AS (Grindeks) focuses on the research, development, manufacture and marketing of original products, generic products and active pharmaceutical ingredients (APIs). Its products are indicated for treating diseases in the cardiovascular system, CNS, oncology, diabetes and skin categories. The company provides final dosage form pharmaceutical products ranging from solid-form products and solutions for injections to syrups and ointments. Grindeks also provides regulatory, analytical and final dosage form contract manufacturing services to pharmaceutical companies. Grindeks operates subsidiary companies in Latvia, Estonia and Slovakia and is headquartered in Riga, Latvia.

Grindeks AS Key Recent Developments

Dec 02,2025: Grindeks Group Introduces CDMO And Out-Licensing Services
Aug 12,2025: Janis Romanovskis Appointed as CEO of JSC “Grindeks”
Aug 06,2025: Strong Growth and Strengthened Market Positions in Europe During the First Half of Grindeks Final Transformation Year
Feb 17,2025: Baltics Leading Pharmaceutical Company Grindeks Expands to New Export Markets Worldwide

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

28 Pages
Section 1 - About the Company
Grindeks AS - Key Facts
Grindeks AS - Key Employees
Grindeks AS - Key Employee Biographies
Grindeks AS - Major Products and Services
Grindeks AS - History
Grindeks AS - Company Statement
Grindeks AS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Grindeks AS - Business Description
Grindeks AS - SWOT Analysis
SWOT Analysis - Overview
Grindeks AS - Strengths
Grindeks AS - Weaknesses
Grindeks AS - Opportunities
Grindeks AS - Threats
Grindeks AS - Key Competitors
Section 3 – Company’s Recent Developments
Dec 02, 2025: Grindeks Group Introduces CDMO And Out‑Licensing Services
Aug 12, 2025: Janis Romanovskis Appointed as CEO of JSC “Grindeks”
Aug 06, 2025: Strong Growth and Strengthened Market Positions in Europe During the First Half of Grindeks Final Transformation Year
Feb 17, 2025: Baltics Leading Pharmaceutical Company Grindeks Expands to New Export Markets Worldwide
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Grindeks AS, Key Facts
Grindeks AS, Key Employees
Grindeks AS, Key Employee Biographies
Grindeks AS, Major Products and Services
Grindeks AS, History
Grindeks AS, Other Locations
Grindeks AS, Subsidiaries
Grindeks AS, Key Competitors

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.